iBio, Inc.
IBIO
$2.22
$0.115.21%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 300.00K | 500.00K | 400.00K | 375.00K | 375.00K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 300.00K | 500.00K | 400.00K | 375.00K | 375.00K |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | 300.00K | 500.00K | 400.00K | 375.00K | 375.00K |
| SG&A Expenses | 12.81M | 10.39M | 10.69M | 10.96M | 10.71M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 25.77M | 20.95M | 19.00M | 17.19M | 15.94M |
| Operating Income | -25.47M | -20.45M | -18.60M | -16.81M | -15.56M |
| Income Before Tax | -24.74M | -20.11M | -18.38M | -16.46M | -14.23M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -24.74 | -20.11 | -18.38 | -16.46 | -14.23 |
| Earnings from Discontinued Operations | -- | -- | -- | -4.53M | -5.07M |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -24.74M | -20.11M | -18.38M | -20.99M | -19.30M |
| EBIT | -25.47M | -20.45M | -18.60M | -16.81M | -15.56M |
| EBITDA | -24.74M | -19.67M | -17.83M | -16.02M | -14.71M |
| EPS Basic | -1.23 | -1.62 | -1.79 | -2.34 | -2.70 |
| Normalized Basic EPS | -0.77 | -1.01 | -1.12 | -1.13 | -1.44 |
| EPS Diluted | -1.23 | -1.62 | -1.79 | -2.34 | -2.70 |
| Normalized Diluted EPS | -0.77 | -1.01 | -1.12 | -1.13 | -1.44 |
| Average Basic Shares Outstanding | 143.05M | 53.05M | 42.02M | 36.21M | 30.06M |
| Average Diluted Shares Outstanding | 143.05M | 53.05M | 42.02M | 36.21M | 30.06M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |